Scinai Immunotherapeutics

SCNINasdaq Israel Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$1.210 M

$0.46 +2.50%

Close of 6 Nov 2026

As of 6 Nov 2026, Scinai Immunotherapeutics (SCNI) has a market capitalization of $1.21M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$1.31M

#3436 by revenue

Earnings

-$8.31M

Loss-making

Shares outstanding

13,872,899,584

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#159Tessera Defense & Homeland SecurityHLSQ$3.22M
#160VivoSim LabsVIVS$2.41M
#161Calidi BiotherapeuticsCLDI$2.32M
#162Silexion TherapeuticsSLXN$2.19M
#163Scinai ImmunotherapeuticsSCNI$1.21M

What if Scinai Immunotherapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$10,734,759

Per share 23,336,433× higher

Bitcoin $1.53T

$580,839.13

Per share 1,262,694× higher

Apple $5.02T

$1,906,841

Per share 4,145,306× higher

Or at a round number

$2.00M $5.00M $10.0M $20.0M

Where these numbers come from

Share counts and financials for Scinai Immunotherapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.